Fortress Biotech (FBIO) EPS (Basic) Growth (5y) (2015 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.81% |
| Dec 31, 2025 | 47.29% |
| Sep 30, 2025 | 15.13% |
| Jun 30, 2025 | 15.78% |
| Mar 31, 2025 | 38.97% |
| Dec 31, 2024 | 44.77% |
| Sep 30, 2024 | 35.01% |
| Jun 30, 2024 | 37.56% |
| Mar 31, 2024 | 27.01% |
| Dec 31, 2023 | 37.34% |
| Sep 30, 2023 | 37.12% |
| Jun 30, 2023 | 22.26% |
| Mar 31, 2023 | 23.79% |
| Dec 31, 2022 | 12.50% |
| Sep 30, 2022 | 22.63% |
| Jun 30, 2022 | 14.33% |
| Mar 31, 2022 | -6.81% |
| Dec 31, 2021 | 0.37% |
| Sep 30, 2021 | -8.52% |
| Jun 30, 2021 | -5.06% |